Abbott Laboratories (ABT): Price and Financial Metrics

ABT POWR Grades

• ABT scores best on the Stability dimension, with a Stability rank ahead of 88.61% of US stocks.
• ABT's strongest trending metric is Growth; it's been moving down over the last 178 days.
• ABT ranks lowest in Momentum; there it ranks in the 29th percentile.

ABT Stock Summary

• ABT has a market capitalization of $183,983,146,200 -- more than approximately 99.2% of US stocks.
• ABBOTT LABORATORIES's stock had its IPO on January 1, 1986, making it an older stock than 93.26% of US equities in our set.
• The volatility of ABBOTT LABORATORIES's share price is greater than that of just 21.81% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to ABT, based on their financial statements, market capitalization, and price volatility, are DHR, TMO, DIS, VZ, and TMUS.
• Visit ABT's SEC page to see the company's official filings. To visit the company's web site, go to www.abbott.com.

ABT Valuation Summary

• In comparison to the median Healthcare stock, ABT's EV/EBIT ratio is 80.68% higher, now standing at 18.7.
• Over the past 243 months, ABT's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for ABT.

ABT Growth Metrics

The 3 year cash and equivalents growth rate now stands at 153.97%.
• Its year over year cash and equivalents growth rate is now at -4.71%.
• Its 4 year net income to common stockholders growth rate is now at 161.43%.

Over the past 33 months, ABT's revenue has gone up $14,193,000,000.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	45,548	10,243	8,554
2022-03-31	44,514	9,961	7,725
2021-12-31	43,075	10,533	7,071
2021-09-30	42,308	11,264	7,244
2021-06-30	40,233	10,629	6,376
2021-03-31	37,338	9,823	5,724

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
• ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
• DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.